Nanavati Super Specialty Hospital, Mumbai – India
About Dr. Adwaita A Gore
Dr. Adwaita Gore is a distinguished and highly respected medical and haemato-oncologist based in Mumbai, with over 15 years of dedicated practice. He is widely regarded as one of the leading oncologists in India, renowned for his dual certification in both medical and blood-related cancers. Dr. Gore’s expertise lies in Personalised and Precision Oncology, where he leverages cutting-edge genetic profiling and targeted therapies to design effective treatment plans. His compassionate, patient-centric approach ensures that patients and their families are guided through every step with clarity and empathy. Through his extensive work in clinical research and leadership roles, including Executive Editor of the Indian Journal of Cancer, he remains at the forefront of oncological advancements, bringing global best practices to his patients in India.
Medical Degrees
- Super-Specialty DNB (Medical Oncology)
- DNB (General Medicine)
- MBBS
- Advanced Hemato & Immuno-Oncology Training: University of Giessen & Marburg, Germany
- ESMO-Certified in Medical Oncology: European Society for Medical Oncology (2010)
Major Cancer Types Treated
- Solid Tumours: Breast Cancer, Lung Cancer, Gastrointestinal Cancers (including Hepatobiliary and Pancreatic), Genito-Urinary Cancers, Gynaecological Cancers, Head & Neck Cancers, Sarcomas (Bone and Soft Tissue).
- Haematological Malignancies: Lymphoma, Leukaemia, Multiple Myeloma.
- Personalised & Precision Oncology
- Immuno-Oncology
- Geriatric (Elderly) Cancers
- Cancer Genetics
- Integrated Palliative Care
- Bone Marrow Transplant (BMT)
- Targeted Therapy Planning and Administration
- Advanced Chemotherapy Protocols
- Immunotherapy Protocols
- Stem Cell Apheresis
- Central Venous Catheter and PICC Line Management
Current & Past Hospital Affiliations
- Associate Director, Medical Oncology - Nanavati Max Institute of Cancer Care, Mumbai
- Consultant Medical Oncologist - Zen Multi Specialty Hospital, Mumbai
- Director & Partner - Oncology Care Associates LLP
- Prince Aly Khan Hospital, Mazgaon
- Global Hospital, Parel
- Kohinoor Hospital, Kurla
- Apollo Hospitals, Navi Mumbai
- Reliance Hospital, Navi Mumbai
- Executive Editor: Indian Journal of Cancer
- Editor/Reviewer: Serves on the board for several peer-reviewed oncology journals.
- Investigator: Actively involved as an investigator in national and international clinical trials.
- Recognised as one of the few dual-certified medical and haemato-oncologists in the Mumbai region.
- Played a pivotal role in establishing and launching the oncology services at BYL Nair Municipal General Hospital in Mumbai.
- Co-founded Oncology Care Associates LLP and the OCA Foundation, which supports underprivileged patients in accessing cancer treatments.
- Extensive experience with over 2,500 successfully treated patients.
Recognitions & Honours
- Acknowledged as one of India's leading cancer specialists for his clinical excellence and compassionate leadership.
- Holds a Distinction in Human Physiology during his MBBS.
- Maintains over 95% positive patient feedback on platforms like Practo, reflecting his trusted and supportive bedside manner.
Published Papers in Medical Journals
- Preemptive and Upfront Plerixafor: Safe and Effective Strategy for Patients Undergoing Autologous Stem Cell transplant and at High Risk for Mobilization Failure. Indian Journal of Medical and Paediatric Oncology (2020)
- Pegfilgrastim: More Cost Effective and Equally Efficacious Option as Compared to Filgrastim in Autologous Stem Cell Transplant. Indian Journal of Hematology and Blood Transfusion (2018)
- Engraftment Syndrome: Clinical Features and Predictive Factors in Autologous Stem Cell Transplant. Indian Journal of Hematology and Blood Transfusion (2017)
- LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy. International Journal of Hematology (2016)
- Efficacy of plerixafor with GCSF for mobilization of PBSC: A single center experience. Journal of Clinical Oncology (2015)
- Engraftment Syndrome following Hematopoietic stem cell transplant: A retrospective review of 70cases. Journal of Clinical Oncology (2015)
- The Etiology of Pleural Effusions Develping During Dasatinib Therapy in CML Could Be Variable: Need for Awareness and Investigations. Blood (2012)
- Comparison of Toxicity and Outcomes of BCNU-Containing Conditioning Regimens Vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis. Blood (2011)
- Chemoradiation for Laryngeal Cancer: Present Scenario. Otorhinolaryngology Clinics - An International Journal (2010)
- "Dr. Gore's approach is a perfect blend of science and compassion. When my mother was diagnosed with breast cancer, he explained every option with incredible patience and clarity. We felt empowered and confident in our decisions. He is truly one of the best oncologists in Mumbai." - S. Sharma
- "Being diagnosed with lymphoma was terrifying, but Dr. Adwaita Gore was a pillar of calm and expertise. His knowledge of haematological cancers is immense. He managed my treatment meticulously, and his supportive nature made a huge difference during the toughest times." - R. Fernandes
- "What stands out about Dr. Gore is his dedication to personalised care. He didn't just see a disease; he saw me as a person. His use of precision oncology felt like we were using the most advanced tools available to fight my cancer. I am deeply grateful for his care." - A. Khan
- Patient-Centred Care: Dr. Gore is committed to delivering compassionate and personalised care. He believes in walking patients and their families through every step of the treatment journey with clarity, transparency, and empathy. His supportive consultation style is designed to ensure patient comfort and build confidence.
- Technology & Innovation: Dr. Gore integrates global best practices from India and Germany into his daily therapy planning. He is a strong advocate for Precision and Personalised Oncology, using genetic profiling, targeted therapies, and cutting-edge immunotherapy protocols to optimise treatment outcomes while minimising side effects. His continuous involvement in clinical trials and research keeps him at the vanguard of cancer therapy.
The cost of treatment can vary significantly based on the type of cancer, the specific treatment protocol (chemotherapy, immunotherapy, targeted therapy), duration of hospital stay, and other medical requirements. For an accurate cost estimate, the Cancer Rounds team can provide a detailed breakdown after a preliminary evaluation of the patient's medical records.
Disclaimer: These are approximate costs and can vary. For a personalised quote, please contact the Cancer Rounds team.
| Treatment/Procedure | Estimated Cost in India (INR) | Estimated Cost in India (USD) |
| Chemotherapy (per cycle) | ₹30,000 - ₹2,50,000 | $360 - $3,000 |
| Immunotherapy (per cycle) | ₹1,50,000 - ₹4,00,000 | $1,800 - $4,800 |
| Targeted Therapy (monthly) | ₹80,000 - ₹3,50,000 | $960 - $4,200 |
| Autologous BMT | ₹12,00,000 - ₹18,00,000 | $14,400 - $21,600 |
- Language Support: The Cancer Rounds team offers comprehensive language support, including interpreters, to ensure clear communication for all international patients.
- Visa & Travel Assistance: Our team provides dedicated assistance with medical visa applications, flight bookings, local travel arrangements, and comfortable accommodation for patients and their families.
- Pre-treatment Virtual Consultations: We facilitate pre-travel virtual consultations with Dr. Gore to discuss the diagnosis, review medical records, and create a preliminary treatment plan, ensuring a smooth and efficient process upon arrival.
Frequently Asked Questions
Dr. Gore is a dually certified expert in Medical Oncology (for solid tumours like breast, lung, and GI cancers) and Haemato-Oncology (for blood cancers like leukaemia, lymphoma, and myeloma). He also specialises in Bone Marrow Transplantation.
Precision Oncology is an advanced approach where a patient's genetic profile is analysed to identify specific mutations driving their cancer. Dr. Gore uses this information to select targeted therapies or immunotherapies that are most likely to be effective, leading to better outcomes and fewer side effects.
Dr. Gore's reputation as a top oncologist in India stems from his dual certification, extensive 15+ years of experience, advanced training in Germany, leadership in research as an editor for a major cancer journal, and his compassionate, patient-first philosophy, which has earned him exceptional patient trust.
Yes, as a highly skilled Haemato-Oncologist, Dr. Gore has deep expertise in treating all types of blood cancers, including lymphomas, leukaemias, and multiple myeloma, often utilising Bone Marrow Transplant as a treatment modality.
A dual certification gives a doctor a comprehensive understanding of all forms of cancer, both solid tumours and blood malignancies. This allows Dr. Gore to manage complex cases that may involve both aspects and to apply learnings from one field to another, offering a holistic and integrated treatment perspective.
Yes, Dr. Gore is a keen researcher. He serves as the Executive Editor of the Indian Journal of Cancer, is an active investigator in clinical trials, and has published numerous papers, ensuring his practice is informed by the latest scientific evidence.
To book an appointment or arrange a virtual consultation with Dr. Adwaita Gore, you can contact the Cancer Rounds team. They will assist you with the entire process, including medical record review and scheduling.
Jaslok Hospital - India
